Physician profile
Omar Chaabo
NPI 1851072714
$5,598.69
in general payments reported to CMS, 2019-2025
17 companies · $3,496 in 2025
The $3,496 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $630 · 2024: $1,473 · 2025: $3,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,137 · Travel and Lodging: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,136.69 |
| Travel and Lodging | $1,462.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,761.12 | 2024-2025 | Optis, Dragonfly Opstar, Diamondback Peripheral |
| Boston Scientific Corporation | $897.49 | 2023-2025 | Synergy, Avvigo Guidance System, Samurai Rc |
| Abiomed | $375.54 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $319.58 | 2024-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $287.54 | 2024-2025 | Corevalve Evolut R, Selectsecure, Linq II |
| Shockwave Medical, INC | $214.16 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $151.30 | 2024 | Angio-Seal, Tr Band |
| Penumbra, INC. | $143.76 | 2025 | Indigo System |
| Janssen Pharmaceuticals, INC | $123.77 | 2024 | Xarelto |
| Philips North America LLC | $123.53 | 2024 | (6342) Intrasight Integrated |
| Bridgebio Pharma, INC. | $41.36 | 2025 | Attruby |
| Novartis Pharmaceuticals Corporation | $37.31 | 2024 | |
| Kestra Medical Technology Services, INC. | $34.02 | 2025 | Assure Wcd |
| Amgen INC. | $33.00 | 2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $20.00 | 2025 | Camzyos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.84 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Chaabo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.